Author

Pengfei Xu

Observed names: P Xu, Peihao Xu, Xu Peikang

Institutions: Tan Tock Seng Hospital, First Affiliated Hospital of Xinjiang Medical University, Second Affiliated Hospital of Guangzhou Medical University, First Affiliated Hospital of Guangzhou Medical University, Zhejiang University

Observed institutions: Tan Tock Seng Hospital, First Affiliated Hospital of Xinjiang Medical University, Second Affiliated Hospital of Guangzhou Medical University, First Affiliated Hospital of Guangzhou Medical University, Zhejiang University

ORCID: 0009-0001-1156-8561

Observed ORCID: 0009-0001-1156-8561

OpenAlex ID: A5136373016

IRE1α/XBP1 suppression reprograms macrophage plasticity and Treg induction to enhance ethylene-carbodiimide-fixed donor splenocytes-induced cardiac allograft tolerance

2026 · Xu Peikang, Chen Guidong, et al. · International Immunopharmacology · 1

Targeting DPP9 attenuates podocyte injury by regulating NRF2 antioxidant signaling

2026 · Chenkai Cui, Shizhuo Wei, et al. · Frontiers in Pharmacology

Mechanistic Study of Deoxyshikonin-Mediated Protection Against High-Glucose-Induced Injury in HUVECs

2026 · Chao Bai, Wenwen Yang, et al. · Research Square

Deoxyshikonin Ameliorates High Glucose-Induced Dysfunction of Human Umbilical Vein Endothelial Cells and Promotes Wound Healing in Diabetic Mice by Regulating hsa-HLA- DRB1

2026 · Chao Bai, Wenwen Yang, et al. · Research Square

Targeted gene panel versus whole-exome sequencing for prenatally diagnosed Human laterality defects

2026 · Yuan Chen, Yeqing Qian, et al. · Research Square

B70-05 Efficacy and Safety of Eravacycline in Lung Transplant Recipients With Multidrug-Resistant Bacteria Infection: A Single-Arm Retrospective Study

2026 · P Xu, J Liang, et al. · American Journal of Respiratory and Critical Care Medicine

Works count: 6

Citation count: 1

H-index: 1

I10-index: